Bugge E, Ytrehus K
Department of Medical Physiology, University of Tromsø, Norway.
Cardiovasc Res. 1995 Mar;29(3):401-6.
The aim was (1) to clarify whether alpha adrenoceptor and adenosine receptor stimulation is involved in the anti-infarct effect of ischaemic preconditioning in the rat heart, and (2) to test the hypothesis that signal transduction through membrane bound protein kinase C is essential for the protection.
Isolated, buffer perfused rat hearts were subjected to 30 min of regional ischaemia and 120 min of reperfusion. The risk zone was determined by fluorescent particles, and infarct size was determined by staining with triphenyltetrazolium chloride.
Ischaemic preconditioning with three cycles of 5 min ischaemia plus 5 min of reperfusion significantly reduced infarct size as compared to non-preconditioned group [4.5(SEM 0.6)% of the risk zone v 45.5(5.7)%, P < 0.001]. Blockade of alpha adrenoceptors alone and simultaneous blockade of alpha adrenoceptors with phenoxybenzamine (10 microM) and adenosine receptors with sulphophenyltheophylline (100 microM) did not prevent the protective effect of ischaemic preconditioning [infarct size = 2.4(0.4) and 5.6(1.9)% respectively, NS v the non-treated preconditioned group]. Blocking either the membrane binding of protein kinase C with polymyxin B (1 microM) or direct inhibition of protein kinase C activity with chelerythrine (2 microM) completely abolished the infarct size reducing effect of ischaemic preconditioning [32.4(3.3)% and 48.2(4.0)% respectively, P < 0.005 v non-treated preconditioned group: NS v the non-preconditioned group].
In the rat heart infarct model the protective effect of ischaemic preconditioning is not mediated through stimulation of alpha adrenoceptors alone or the combined stimulation of alpha adrenergic and adenosine receptors, and it is dependent on activation of membrane bound protein kinase C.
(1)明确α肾上腺素能受体和腺苷受体的刺激是否参与大鼠心脏缺血预处理的抗梗死作用;(2)验证通过膜结合蛋白激酶C的信号转导对这种保护作用至关重要这一假说。
将分离的、用缓冲液灌注的大鼠心脏进行30分钟的局部缺血和120分钟的再灌注。用荧光颗粒确定危险区,用氯化三苯基四氮唑染色确定梗死面积。
与未预处理组相比,进行三个5分钟缺血加5分钟再灌注周期的缺血预处理显著减小了梗死面积[梗死面积占危险区的比例分别为4.5(标准误0.6)%和45.5(5.7)%,P<0.001]。单独阻断α肾上腺素能受体以及用酚苄明(10微摩尔)同时阻断α肾上腺素能受体和用磺酰苯甲酰基茶碱(100微摩尔)阻断腺苷受体均不能阻止缺血预处理的保护作用[梗死面积分别为2.4(0.4)%和5.6(1.9)%,与未处理的预处理组相比无显著差异]。用多粘菌素B(1微摩尔)阻断蛋白激酶C的膜结合或用白屈菜红碱(2微摩尔)直接抑制蛋白激酶C活性均完全消除了缺血预处理减小梗死面积的作用[分别为32.4(3.3)%和48.2(4.0)%,与未处理的预处理组相比P<0.005;与未预处理组相比无显著差异]。
在大鼠心脏梗死模型中,缺血预处理的保护作用不是通过单独刺激α肾上腺素能受体或联合刺激α肾上腺素能和腺苷受体介导的,而是依赖于膜结合蛋白激酶C的激活。